ConferencePoster
 (2010)

Induction of TH1/TH17 and inhibition of TH3 Cellular Profile by DC-based Immunotherapy is Associated with Immunological and Clinical anti-Tumor Responses in Melanoma Patients.

Duran-Aniotz C.; Segal G.; Salazar L.; Pereda C.; Tempio F.; Salazar-Onfray F.; Lopez M.N.